Cancer Cachexia Market Share, Analysis, Growth, Trends 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Cancer Cachexia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global cancer cachexia market share, size and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Cancer Cachexia Market?
The global cancer cachexia market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.5% during 2023-2028.
What is Cancer Cachexia?
Cancer cachexia is a serious condition generally observed in cancer patients that causes severe weight loss, muscle wasting, loss of appetite, and overall decline in physical functioning. It is more prevalent in advanced stages of cancer and can impact the quality of life of patients, treatment response, and overall prognosis. It is caused due to the occurrence of various chronic diseases, such as tuberculosis (TB), chronic obstructive pulmonary disease (COPD), and multiple sclerosis. Besides this, it can be treated through nutritional interventions, pharmacological interventions, and exercise and physical therapy.
Request Free Sample Copy of This Report: https://www.imarcgroup.com/cancer-cachexia-market/requestsample
What are the growth prospects and trends in the cancer cachexia industry?
At present, the increasing prevalence of cancer among the masses across the globe represents one of the primary factors impelling the growth of the market. Apart from this, the growing demand for cancer cachexia treatment solutions among the geriatric population, as they have a reduced ability to tolerate aggressive cancer treatments, is positively influencing the market outlook.
Additionally, the rising emergence of novel therapies that focus on improving muscle mass, appetite stimulation, and overall patient well-being is strengthening the growth of the market. Besides this, the increasing focus on personalized medicine among the masses around the world is bolstering the growth of the market.
Furthermore, the rising awareness about the availability of novel therapeutic drugs to treat cancer cachexia among individuals is supporting the growth of the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Therapeutics:
- Progestogens
- Corticosteroids
- Combination Therapy
- Others
Breakup by Mode of Action:
- Appetite Stimulators
- Weight Loss Stabilizers
Breakup by Distribution Channel:
- Hospital Stores
- Retail Pharmacy
- Online Pharmacy
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
